Haptoglobin polymorphism and iron homeostasis

Clinical Chemistry

Volumn 48, Issue 12, 2002, Pages 2232-2235

  Beutler, Ernest ^a   Gelbart, Terri ^a   Lee, Pauline ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HAPTOGLOBIN; IRON; OLIGONUCLEOTIDE; TRANSFERRIN;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HEMOCHROMATOSIS; HOMEOSTASIS; HOMOZYGOSITY; HUMAN; HYBRIDIZATION; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHENOTYPE;

EID: 0036893006     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.12.2232     Document Type: Article

References (18)

1. Beutler E, Felitti V, Gelbart T, Ho N. The effect of HFE genotypes in patients attending a health appraisal clinic. Ann Intern Med 2000;133:329-37.
2. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of the 845G6A (C282Y) HFE hereditary haemochromatosis mutation in the U S A. Lancet 2002;359:211-8.
3. Delanghe JR, Langlois MR. Haptoglobin polymorphism and body iron stores. Clin Chem Lab Med 2002;40:212-6.
4. Langlois MR, Martin ME, Boelaert JR, Beaumont C, Taes YE, De Buyzere ML, et al. The haptoglobin 2-2 phenotype affects serum markers of iron status in healthy males. Clin Chem 2000;46:1619-25.
5. Van Vlierberghe H, Langlois M, Delanghe J, Horsmans Y, Michielsen P, Henrion J, et al. Haptoglobin phenotype 2-2 over-representation in Cys282Tyr hemochromatotic patients. J Hepatol 2001;35:707-11.
6. Waalen J, Felitti V, Gelbart T, Ho NJ, Beutler E. Prevalence of hemochromatosis-related symptoms in homozygotes for the C282Y mutation of the HFE gene. Mayo Clin Proc 2002;77:522-30.
7. Craig WY, Forster NR, Ledue TB, Johnson AM, Neveux LM, Ritchie RF. An improved method for determining high molecular weights by protein immunoblotting: Application to apolipoprotein(a) phenotyping. Appl Theor Electrophor 1991;2:135-40.
8. Beutler E. Discrepancies between genotype and phenotype in hematology: An important frontier. Blood 2001;98:2597-602.
9. Lee PL, Gelbart T, West C, Halloran C, Felitti V, Beutler E. A study of genes that may modulate the expression of hereditary hemochromatosis: Transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin. Blood Cells Mol Dis 2001;27:783-802.
10. Lee PL, Halloran C, Trevino R, Felitti V, Beutler E. Human transferrin G277S mutation: A risk factor for iron deficiency anaemia. Br J Haematol 2001;115:329-33.
11. Okuda M, Tokunaga R, Taketani S. Expression of haptoglobin receptors in human hepatoma cells. Biochim Biophys Acta 1992; 1136:143-9.
12. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SKA, et al. Identification of the haemoglobin scavenger receptor. Nature 2001;409:198-201.
13. Garby L, Noyes WD. Studies on hemoglobin metabolism. I. The kinetic properties of the plasma hemoglobin pool in normal man. J Clin Invest 1959;38:1479.
14. Koda Y, Soejima M, Yoshioka N, Kimura H. The haptoglobin-gene deletion responsible for anhaptoglobinemia. Am J Hum Genet 1998;62:245-52.
15. Nishiki S, Hino M, Kumura T, Hashimoto S, Ohta K, Yamane T, et al. Effectiveness of washed platelet concentrate and red cell transfusions for a patient with anhaptoglobinemia with antihaptoglobin antibody. Transfus Med 2002;12:71-3.
16. Lim SK, Kim HK, Bin A, Lim YK, Wang YP, Chong SM, et al. Increased susceptibility in Hp knockout mice during acute hemolysis. Blood 1998;92:1870-7.
17. Kanakoudi F, Drossou V, Tzimouli V, Diamanti E, Konstantinidis T, Germenis A, et al. Serum concentrations of 10 acute-phase proteins in healthy term and preterm infants from birth to age 6 months. Clin Chem 1995;41:605-8.
18. Kasvosve I, Gordeuk VR, Delanghe JR, Gomo ZAR, Gangaidzo IT, Khumalo H, et al. Iron status in black persons is not influenced by haptoglobin polymorphism. Clin Chem Lab Med 2002;40:810-3.